HLK Biotech Holding Group, Inc.

OTC: AMHD · Healthcare · Drug Manufacturers - Specialty & Generic

PublicHQ Norfolk, VA · Norfolk (Independent City)Reports USD

#1 of 1,418 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 35

v0.1 · 5/100 weight · pillars only

↑ listing tenure, workforce scale · ↓ market scale, workforce scale

Methodology →

Revenue TTM

—

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

—

Employees

as of 2026-08-03

Market cap

$925

as of 2026-08-03

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

No filed financials — private or non-XBRL filer.

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is HLK Biotech Holding Group, Inc.’s financial profile?

HLK Biotech Holding Group, Inc. has no structured financials on file — private or non-XBRL filer.

Peers · Healthcare

MSP Recovery, Inc.——PsyBio Therapeutics Corp——FusionPharm, Inc.——Sunset Island Group, Inc.——NxGen Brands Inc.——AXM Pharma, Inc.——

Neighbors

Norfolk (Independent City) →

PRA Group, Inc.$1.2B49D

Key facts

CEOAnna Petinova

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersNorfolk, VA

ExchangeOTC: AMHD

Employees5

IPO date1999-02-11

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.